- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
- 3 Software Stock Picks from Lazard's Senior Analyst
- Investors Bet on a New Year's Rally For eBay
- Why You Should Play the Reflation Trade: Stock Picker
- S&P to Hit 1,200 by Year-End: Chief Investor
- 5 Big Bank Stocks Investors Should Consider: Strategists
- My 2010 Home Price Outlook: UBS Analyst
MOST SHARED
- Ritz-Carlton ?Struggling? in the US: President
- Garlic Price Rises Surpass Gold, Stocks in China
- S&P Stocks Trading at New 52-Week Highs
- New-Home Sales Jump 6.2% To Highest Level in Over Year
- Half of Banks' Losses May Still Be Hidden: IMF Head
- The Executive Job Search
- Consumer Mood Improves, But Anxiety Over Personal Finances
- Salvation Army's Kettles Now Credit Card-Ready
- Activision Prepares to Double Dip on ‘Modern Warfare 2’
- Where Do Pardoned Turkeys Go?
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
- S&P Stocks Trading at New 52-Week Highs
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- 'Cancer of Fraud' Permeates Health Care System: Critics
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Judge Erases Couple's $525,000 Mortgage Payment
- For Many in US, It Will Be a Scaled-Down Holiday Season
- Where Do Pardoned Turkeys Go?
- Foreign Demand Boosts US 7-Year Treasury Sale
- Jobless Claims Below 500,000, Durable Orders Slip
- Activision Prepares to Double Dip on ‘Modern Warfare 2’
- Garlic Price Rises Surpass Gold, Stocks in China
RSS FEED
CNBC Stock Blog
Text Size 
Healthcare reform may take longer than its proponents had hoped, but it's coming, and Arthur Henderson of Jefferies has pinpointed some stocks that stand to gain traction.
"There's just not enough money to fund a big healthcare reform bill," he told CNBC. "I do think that there are some tweaks that can be done to expand eligibility for children, as well as emphasis on more cost containment."
Recommendations:
Topping his list of stock picks are home nursing providers LHC Group [LHCG
Loading...
()
] and Amedisys [AMED
Loading...
()
].
"Whether there's reform or not, these companies are lower-cost alternative settings," he said. "You can get great clinical care at a much lower price than you can in an inpatient setting, so I think as they look for ways to fund expanded eligibility, areas like this that they can get more people into are going to benefit."
He also likes pharmacy benefit manager Express Scripts [ESRX
Loading...
()
].
"Generic utilization is going to go up," he explained. "We're already seeing it; companies are exchanging their formularies to get more people on these generic drugs. PBMs like Express Scripts are going to do well in that circumstance."
Rounding out his selections is Emergency Medical Services [EMS
Loading...
()
].
"Communities—cities, municipalities—that are having trouble funding ambulance services are going to turn to outsource providers like EMS that are much more efficient," he said.
Disclosures:
Neither Henderson, his family, nor his firm owns shares in, or has any business relationship with, LHC Group, Amedisys, Express Scripts, or Emergency Medical Services.
Data is a real-time snapshot *Data is delayed at least 15 minutes